Health
Expediting trip from bench to bedside
NEWS IN BRIEF — Posted Jan. 5, 2004
The AMA will work to eliminate the barriers of applying biomedical research to clinical practice.
A new policy position adopted during the House of Delegates December 2003 Interim Meeting in Honolulu was in response to complaints from physicians who often feel stymied in their attempts to gain access for patients to the latest medical treatments.
"Translational research -- taking bench science to the bedside -- is probably one of the most important and underserved issues in care today," said Duane Whitaker, MD, an American Society for Dermatologic Surgery delegate.
The AMA will work with specialty societies, the American Assn. for the Advancement of Science, the Institute of Medicine's Clinical Research Roundtable, federal agencies and other organizations to develop means to increase the speed at which new scientific advances work their way into clinical practice.
The progress report will be given to the House of Delegates when it reconvenes in June in Chicago.
Note: This item originally appeared at http://www.ama-assn.org/amednews/2004/01/05/hlbf0105.htm.